Drug-Eluting Stents Pose No Greater Risk: Study

Law360, New York (November 5, 2007, 12:00 AM EST) -- Patients who received drug-eluting stents are no more likely to die or suffer a heart attack than those who receive bare-metal versions, according to a recent U.S. study, the latest development in the debate over the safety of the artery-opening devices.

The study, called the Massachusetts stent trial, compared death rates of patients who received drug-eluting stents to those who received bare metal stents between April 1, 2003 and Dec. 31, 2004, and found the drug-coated stents did not result in an increased rate of death...
To view the full article, register now.